Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nick Devoogdt

Showing results (31-40 of 153) with videos related to

Pageof 16
Sort By:
Current Opinion in Biotechnology|July 6, 2011
Immuno-imaging using nanobodiesIlse Vaneycken, Matthias D'huyvetter, Sophie Hernot, et al.
Molecular Pharmaceutics|March 1, 2017
Effect of Dye and Conjugation Chemistry on the Biodistribution Profile of Near-Infrared-Labeled Nanobodies as Tracers for Image-Guided SurgeryPieterjan Debie, Jannah Van Quathem, Inge Hansen, et al.
International Journal of Molecular Sciences|April 3, 2021
Mechanisms Underlying Connexin Hemichannel Activation in DiseaseRaf Van Campenhout, Ana Rita Gomes, Timo W M De Groof, et al.
Pharmaceuticals (Basel, Switzerland)|October 29, 2025
Design and Preclinical Validation of an Anti-B7-H3-Specific Radiotracer: A Non-Invasive Imaging Tool to Guide B7-H3-Targeted TherapiesCyprine Neba Funeh, Fien Meeus, Niels Van Winnendael, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 17, 2018
Same-Day Imaging Using Small Proteins: Clinical Experience and Translational Prospects in OncologyAhmet Krasniqi, Matthias D'Huyvetter, Nick Devoogdt, et al.
Immunobiology|August 14, 2012
Novel applications of nanobodies for in vivo bio-imaging of inflamed tissues in inflammatory diseases and cancerSteve Schoonooghe, Damya Laoui, Jo A Van Ginderachter, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 1, 2014
Improved tumor targeting of anti-HER2 nanobody through N-succinimidyl 4-guanidinomethyl-3-iodobenzoate radiolabelingMarek Pruszynski, Eftychia Koumarianou, Ganesan Vaidyanathan, et al.
New Biotechnology|February 1, 2020
Reshaping nanobodies for affinity purification on protein aMaxine Crauwels, Nele Van Vaerenbergh, Neeme Benedict Kulaya, et al.
Biochemical Pharmacology|January 8, 2026
A comparative in vitro analysis of pannexin1-targeting agentsDaan Peeters, Debora Iaculli, Steven Ballet, et al.
Molecular Imaging and Biology|April 2, 2014
Specific targeting of atherosclerotic plaques in ApoE(-/-) mice using a new Camelid sdAb binding the vulnerable plaque marker LOX-1Jens De Vos, Iris Mathijs, Catarina Xavier, et al.
Pageof 16

Showing results (31-40 of 153) with videos related to

Sort By:
Pageof 16
Current Opinion in Biotechnology|July 6, 2011
Immuno-imaging using nanobodiesIlse Vaneycken, Matthias D'huyvetter, Sophie Hernot, et al.
Molecular Pharmaceutics|March 1, 2017
Effect of Dye and Conjugation Chemistry on the Biodistribution Profile of Near-Infrared-Labeled Nanobodies as Tracers for Image-Guided SurgeryPieterjan Debie, Jannah Van Quathem, Inge Hansen, et al.
International Journal of Molecular Sciences|April 3, 2021
Mechanisms Underlying Connexin Hemichannel Activation in DiseaseRaf Van Campenhout, Ana Rita Gomes, Timo W M De Groof, et al.
Pharmaceuticals (Basel, Switzerland)|October 29, 2025
Design and Preclinical Validation of an Anti-B7-H3-Specific Radiotracer: A Non-Invasive Imaging Tool to Guide B7-H3-Targeted TherapiesCyprine Neba Funeh, Fien Meeus, Niels Van Winnendael, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 17, 2018
Same-Day Imaging Using Small Proteins: Clinical Experience and Translational Prospects in OncologyAhmet Krasniqi, Matthias D'Huyvetter, Nick Devoogdt, et al.
Immunobiology|August 14, 2012
Novel applications of nanobodies for in vivo bio-imaging of inflamed tissues in inflammatory diseases and cancerSteve Schoonooghe, Damya Laoui, Jo A Van Ginderachter, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 1, 2014
Improved tumor targeting of anti-HER2 nanobody through N-succinimidyl 4-guanidinomethyl-3-iodobenzoate radiolabelingMarek Pruszynski, Eftychia Koumarianou, Ganesan Vaidyanathan, et al.
New Biotechnology|February 1, 2020
Reshaping nanobodies for affinity purification on protein aMaxine Crauwels, Nele Van Vaerenbergh, Neeme Benedict Kulaya, et al.
Biochemical Pharmacology|January 8, 2026
A comparative in vitro analysis of pannexin1-targeting agentsDaan Peeters, Debora Iaculli, Steven Ballet, et al.
Molecular Imaging and Biology|April 2, 2014
Specific targeting of atherosclerotic plaques in ApoE(-/-) mice using a new Camelid sdAb binding the vulnerable plaque marker LOX-1Jens De Vos, Iris Mathijs, Catarina Xavier, et al.
Pageof 16